Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Myklebust MP, Fluge Ø, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O.

Br J Cancer. 2012 Feb 14;106(4):756-62. doi: 10.1038/bjc.2011.548.

2.

Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.

Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ.

Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):309-14.

PMID:
10487550
3.
4.

Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.

Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH.

Dis Colon Rectum. 2005 Sep;48(9):1742-51.

PMID:
15991058
5.

[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Hannoun L, Houry S, Huguet F, Pène F, Parc R, Schlienger M.

Cancer Radiother. 2006 Dec;10(8):572-82. Epub 2006 Nov 15. French.

PMID:
17110148
6.

Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN.

Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1115-25.

PMID:
1938508
7.

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.

Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N.

Cancer. 2003 Mar 1;97(5):1195-202.

8.

Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.

Fraunholz I, Rödel F, Kohler D, Diallo-Georgiopoulou M, Distel L, Falk S, Rödel C.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):901-7. doi: 10.1016/j.ijrobp.2013.03.039. Epub 2013 Jun 5.

PMID:
23755922
9.

Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

Seo Y, Kinsella MT, Reynolds HL, Chipman G, Remick SC, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):143-9. doi: 10.1016/j.ijrobp.2008.10.046. Epub 2009 Feb 7.

PMID:
19203845
10.

Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?

Grabenbauer GG, Matzel KE, Schneider IH, Meyer M, Wittekind C, Matsche B, Hohenberger W, Sauer R.

Dis Colon Rectum. 1998 Apr;41(4):441-50.

PMID:
9559628
11.

Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion.

Getsios S, Amargo EV, Dusek RL, Ishii K, Sheu L, Godsel LM, Green KJ.

Differentiation. 2004 Oct;72(8):419-33.

PMID:
15606501
12.

Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.

Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ, Lopes A.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1136-42.

PMID:
15752894
13.

[Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Houry S, Gallot D, Parc R, Huang R, Qu SH, Pène F, Schlienger M.

Cancer Radiother. 2003 Aug;7(4):237-53. French.

PMID:
12914857
14.

Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.

Graf R, Wust P, Hildebrandt B, Gögler H, Ullrich R, Herrmann R, Riess H, Felix R.

Oncology. 2003;65(1):14-22.

PMID:
12837978
15.

Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.

Klas JV, Rothenberger DA, Wong WD, Madoff RD.

Cancer. 1999 Apr 15;85(8):1686-93. Review.

PMID:
10223561
16.

[Outcome of simultaneous radiochemotherapy of anal carcinoma].

Fraunholz IB, Adamietz IA, Lorenz M, Staib-Sebler E, Böttcher HD.

Zentralbl Chir. 1997;122(1):39-43. German.

PMID:
9133135
17.

Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.

Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, Welton ML, Shelton A, Kapp DS, Koong AC, Goodman KA, Chang DT.

Cancer. 2011 Aug 1;117(15):3342-51. doi: 10.1002/cncr.25901. Epub 2011 Feb 1.

18.

Conservative management of squamous cell carcinoma of the anal canal.

Basser RL, Smith JG, Worotniuk V, Guiney MJ.

Aust N Z J Surg. 1994 Nov;64(11):754-8.

PMID:
7945082
19.
20.

[Treatment of advanced anal cancer].

Norum J, Wist E.

Nord Med. 1992;107(8-9):227-8. Norwegian.

PMID:
1408730

Supplemental Content

Support Center